DXX: System, Catheter Control, Steerable
What it covers
A steerable catheter control system is a device that is connected to the proximal end of a steerable guide wire that controls the motion of the steerable catheter.
The identification in 21 CFR 870.1290, steerable catheter control system. FDA gives DXX no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K262744 | GenesisX RMN | Stereotaxis, Inc. | Aug 27, 2026 | Special |
| K251792 | Stereotaxis GenesisX RMN with Navigant Workstation (NWS) | Stereotaxis, Inc. | Nov 6, 2025 | Traditional |
| K243789 | LIBERTY Endovascular Robotic System (LIBERTYOS) | Microbot Medical , Ltd. | Sep 4, 2025 | Traditional |
| K221464 | CorPath GRX System | Corindus, Inc. | Jul 27, 2022 | Special |
| K202275 | CorPath GRX System | Corindus, Inc. | Dec 11, 2020 | Traditional |
| K180517 | CorPath GRX System | Corindus, Inc. | Mar 29, 2018 | Special |
| K173806 | CorPath GRX System | Corindus, Inc. | Mar 1, 2018 | Traditional |
| K173288 | CorPath GRX System | Corindus, Inc. | Feb 15, 2018 | Traditional |
| K160121 | CorPath GRX System | Corindus, Inc. | Oct 27, 2016 | Traditional |
| K152999 | CorPath 200 System | Corindus, Inc. | Mar 18, 2016 | Traditional |
Clearances by year
23 DXX 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 24 |
| 2025 | 2 | 209 |
| 2022 | 1 | 69 |
| 2020 | 1 | 122 |
| 2018 | 3 | 76 |
| 2016 | 2 | 220 |
| 2015 | 4 | 156 |
| 2014 | 4 | 104 |
| 2013 | 1 | 59 |
| 2012 | 4 | 155 |
Who submits
7 applicants cleared a DXX device since 2011. 96% of the clearances went to applicants in United States, then Israel (4%). By type: Traditional 74% and Special 26%.
| Applicant | Clearances since 2011 |
|---|---|
| Corindus, Inc. | 9 |
| Stereotaxis, Inc. | 5 |
| Hansen Medical, Inc. | 4 |
| Catheter Robotics, Inc. | 2 |
| Hansen Medical | 1 |
| Hanson Medical, Inc. | 1 |
| Microbot Medical , Ltd. | 1 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.1290.
Standards
21 CFR 870.1290 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DXX clearances declared.
Ask about DXX
Questions about DXX
What is FDA product code DXX?
Product code DXX, “System, Catheter Control, Steerable” in FDA's classification database, is a Class II device type under 21 CFR 870.1290 (steerable catheter control system), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 34 clearances under DXX, 23 of them since 2011.
How many 510(k) clearances are there under DXX?
FDA’s 510(k) database listed 34 clearances under DXX as of Oct 29, 2026, 23 of them decided since 2011; the most recent decision was Aug 27, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a DXX 510(k)?
For the 3 DXX clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 148 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most DXX clearances?
Since 2011: Corindus, Inc. (9), Stereotaxis, Inc. (5), Hansen Medical, Inc. (4), Catheter Robotics, Inc. (2) and Hansen Medical (1). 7 applicants have cleared a DXX device in that time.